Clinical Trials Browser

Phase 1/2 × Thalidomide × Dermatologic × Clear all

NCT00005815 2013-06-19

Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV Melanoma

Phase 1/2 Completed

Uveal Melanoma, Melanoma